Medicine
BESREMi 500 mcg/1 mL injection
BESREMi 500 mcg/1 mL injection is a prescription medicine containing Ropeginterferon alfa-2b for subcutaneous use, marketed by PharmaEssentia, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store in the refrigerator between 36°F to 46°F (2°C to 8°C) in the original…
Key facts
- Active ingredient (INN)
- Ropeginterferon alfa-2b
- Brand
- BESREMi
- Strength
- 500 mcg/1 mL
- Dosage form
- Injection
- Route
- Subcutaneous
- Packs
- 1 syringe of 1 mL
- Marketing authorisation holder
- PharmaEssentia
- Manufacturer
- PharmaEssentia
- Origin register
- US FDA, United States
- Storage
- Store in the refrigerator between 36°F to 46°F (2°C to 8°C) in the original carton to protect from light. DO NOT FREEZE.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L03AB15 Ropeginterferon alfa-2b
- HS code (indicative)
- 3002.15Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 12 November 2021
- Identifiers
- RxCUI 2587064, 2587070, 2748665 +1DailyMed set ID 9583405d-53a0-49dc-88eb-5e6384ebabcbNDC 73536-500Application BLA761166
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 syringe, glass in 1 carton / 1 mL in 1 syringe, glass | 73536-500-01 | PharmaEssentia | 12 November 2021 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Ropeginterferon alfa-2b
Clinical summary
Ropeginterferon alfa-2b is an interferon alfa-2b indicated for the treatment of adults with essential thrombocythemia, among other approved uses. It is available as injection for subcutaneous use. MedsAcross supplies Ropeginterferon alfa-2b for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Ropeginterferon alfa-2bFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- BESREMi prescribing information (PharmaEssentia) · U.S. National Library of Medicine, DailyMed
- Besremi: European public assessment report (EPAR) · European Medicines Agency
Need BESREMi 500 mcg/1 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.